Back
Lam Research Vs. Denali Therapeutics Industry Stock Comparison
Sell
42
LRCX
Lam Research
Last Price:
798.34
Seasonality Move:
7.58%
Buy
56
DNLI
Denali Therapeutics
Last Price:
31.29
Seasonality Move:
17.79%
Sell
42
Lam Research (LRCX)
is a Sell
Is Lam Research a Buy, Sell or Hold?
- The current Lam Research [LRCX] share price is $755.83. The Score for LRCX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- LRCX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
56
Denali Therapeutics (DNLI)
is a Buy
Is Denali Therapeutics a Buy, Sell or Hold?
- The current Denali Therapeutics [DNLI] share price is $30.76. The Score for DNLI is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- DNLI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LRCX Stock Price Chart
What is Lam Research's stock price today?
-
The Lam Research share price today is $755.83
The current trend is relatively stagnant and LRCX is experiencing selling pressure, which indicates risk of future bearish movement.
DNLI Stock Price Chart
What is Denali Therapeutics's stock price today?
-
The Denali Therapeutics share price today is $30.76
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DNLI is experiencing selling pressure, which indicates risk of future bearish movement.
LRCX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -28.57 | Sell |
Relative Strength Index (14 RSI): | 41.2 | Sell |
Chaikin Money Flow: | -657457 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (750.49 - 851.11) | Sell |
Bollinger Bands (100): | (811.36 - 1025.08) | Sell |
DNLI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.79 | Buy |
Relative Strength Index (14 RSI): | 78.12 | Buy |
Chaikin Money Flow: | -939708 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.39 - 28.19) | Buy |
Bollinger Bands (100): | (19.07 - 25.27) | Buy |
LRCX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 753.81 | Buy |
20-day SMA: | 783.47 | Sell |
50-day SMA: | 853.91 | Sell |
200-day SMA: | 891.51 | Sell |
8-day EMA: | 760.38 | Sell |
20-day EMA: | 781.61 | Sell |
50-day EMA: | 838.99 | Sell |
200-day EMA: | 856.46 | Sell |
DNLI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.69 | Buy |
20-day SMA: | 26.4 | Buy |
50-day SMA: | 24.37 | Buy |
200-day SMA: | 20.59 | Buy |
8-day EMA: | 29.03 | Buy |
20-day EMA: | 26.97 | Buy |
50-day EMA: | 24.8 | Buy |
200-day EMA: | 22.21 | Buy |
Lam Research Earnings Growth & LRCX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.41 per share, an increase next quarter of $2.22 per share, a decrease this year of $3.24 per share, and an increase next year of $6.04 per share.
Denali Therapeutics Earnings Growth & DNLI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.52 per share, and a decrease next year of $0.07 per share.
Lam Research Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Denali Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |